Acrux Company Top Insiders
| ARUXF Stock | USD 0.01 0.00 0.00% |
Acrux employs about 18 people. The company is managed by 4 executives with a total tenure of roughly 42 years, averaging almost 10.0 years of service per executive, having 4.5 employees per reported executive. Examination of Acrux's management performance can provide insight into the company performance.
| BSc BSc Director Product Director |
| Mark Hyman Insider Project Director |
Acrux |
Acrux Management Team Effectiveness
The company has return on total asset (ROA) of (0.4307) % which means that it has lost $0.4307 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7136) %, meaning that it generated substantial loss on money invested by shareholders. Acrux's management efficiency ratios could be used to measure how well Acrux manages its routine affairs as well as how well it operates its assets and liabilities.Acrux Workforce Comparison
Acrux Limited is rated third in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 121. Acrux retains roughly 18.0 in number of employees claiming about 15% of stocks in Biotechnology industry.
Acrux Limited Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Acrux Limited Price Series Summation is a cross summation of Acrux price series and its benchmark/peer.
Acrux Notable Stakeholders
An Acrux stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Acrux often face trade-offs trying to please all of them. Acrux's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Acrux's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| BSc BSc | Product Director | Profile | |
| Mark Hyman | Project Director | Profile | |
| BE BEc | CFO Sec | Profile | |
| Charles Pharm | Portfolio Director | Profile |
About Acrux Management Performance
The success or failure of an entity such as Acrux Limited often depends on how effective the management is. Acrux management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Acrux management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Acrux management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company was incorporated in 1998 and is based in West Melbourne, Australia. Acrux operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Acrux Workforce Analysis
Traditionally, organizations such as Acrux use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Acrux within its industry.Acrux Manpower Efficiency
Return on Acrux Manpower
| Revenue Per Employee | 95.5K | |
| Revenue Per Executive | 429.8K | |
| Net Loss Per Employee | 546.3K | |
| Net Loss Per Executive | 2.5M | |
| Working Capital Per Employee | 1.6M | |
| Working Capital Per Executive | 7M |
Complementary Tools for Acrux Pink Sheet analysis
When running Acrux's price analysis, check to measure Acrux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrux is operating at the current time. Most of Acrux's value examination focuses on studying past and present price action to predict the probability of Acrux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrux's price. Additionally, you may evaluate how the addition of Acrux to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |